malondialdehyde has been researched along with limbrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamo, EB; Altavilla, D; Bitto, A; Calò, M; Galfo, F; Interdonato, M; Irrera, N; Marini, H; Minutoli, L; Pallio, G; Pizzino, G; Rinaldi, M; Squadrito, F; Trichilo, V | 1 |
| Abdelaziz, RR; Elsayed, FF; Elshenawy, WM; Khalifa, EM; Rizq, MR | 1 |
2 other study(ies) available for malondialdehyde and limbrel
| Article | Year |
|---|---|
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.
Topics: Animals; Behavior, Animal; Brain Edema; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Hippocampus; Kainic Acid; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Malondialdehyde; MAP Kinase Signaling System; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Tumor Necrosis Factor-alpha | 2015 |
Ameliorative effect of flavocoxid on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF/NF-κB signaling pathway.
Topics: Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Caspase 3; Catechin; Creatine Kinase; Cyclooxygenase 2; Cyclophosphamide; Drug Combinations; Glutathione; Granulocyte-Macrophage Colony-Stimulating Factor; Immunosuppressive Agents; Interleukins; Lactate Dehydrogenases; Macrophage Colony-Stimulating Factor; Malondialdehyde; Mice; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidases; Signal Transduction; Superoxide Dismutase; Troponin I; Tumor Necrosis Factor-alpha | 2022 |